184 related articles for article (PubMed ID: 33726680)
1. Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Chen H; Luo M; Wang X; Liang T; Huang C; Huang C; Wei L
Cell Mol Biol Lett; 2021 Mar; 26(1):9. PubMed ID: 33726680
[TBL] [Abstract][Full Text] [Related]
2. PAD4 inhibitor promotes DNA damage and radiosensitivity of nasopharyngeal carcinoma cells.
Chen H; Wei L; Luo M; Wang X; Zhan Y; Mao Y; Huang C; Li J; Lu H
Environ Toxicol; 2021 Nov; 36(11):2291-2301. PubMed ID: 34363436
[TBL] [Abstract][Full Text] [Related]
3. GSK484, an inhibitor of peptidyl arginine deiminase 4, increases the radiosensitivity of colorectal cancer and inhibits neutrophil extracellular traps.
Wang B; Su X; Zhang B; Pan S
J Gene Med; 2023 Sep; 25(9):e3530. PubMed ID: 37203323
[TBL] [Abstract][Full Text] [Related]
4. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
Chen H; Wei L; Luo M; Wang X; Zhu C; Huang H; Liu X; Lu H; Zhong Y
Cell Biol Toxicol; 2022 Dec; 38(6):995-1011. PubMed ID: 34322788
[TBL] [Abstract][Full Text] [Related]
5. PADI4, negatively regulated by miR-335-5p, participates in regulating the proliferation, migration, invasion and radiosensitivity of nasopharyngeal carcinoma cells.
Wei LN; Luo M; Wang XP; Liang T; Huang CJ; Chen H
J Biol Regul Homeost Agents; 2021; 35(1):117-129. PubMed ID: 33593046
[TBL] [Abstract][Full Text] [Related]
6. The PAD4 inhibitor GSK484 enhances the radiosensitivity of triple-negative breast cancer.
Wei L; Wang X; Luo M; Wang H; Chen H; Huang C
Hum Exp Toxicol; 2021 Jul; 40(7):1074-1083. PubMed ID: 33355008
[TBL] [Abstract][Full Text] [Related]
7. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
He W; Jin H; Liu Q; Sun Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
[TBL] [Abstract][Full Text] [Related]
8. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
[TBL] [Abstract][Full Text] [Related]
9. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
10. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
11. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
12. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
Zhang Y; Zhang W
Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.
Du M; Yang W; Schmull S; Gu J; Xue S
Int Immunopharmacol; 2020 Jan; 78():106055. PubMed ID: 31816575
[TBL] [Abstract][Full Text] [Related]
14. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
[TBL] [Abstract][Full Text] [Related]
15. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
Tang J; Liu ZY; Tang Y; Wang Y
Hum Exp Toxicol; 2021 Jun; 40(6):977-993. PubMed ID: 33305599
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-195-3p inhibits cyclin dependent kinase 1 to induce radiosensitivity in nasopharyngeal carcinoma.
Xie F; Xiao W; Tian Y; Lan Y; Zhang C; Bai L
Bioengineered; 2021 Dec; 12(1):7325-7334. PubMed ID: 34585634
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
Shen Z; Wu Y; He G
Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Numb/Notch signaling pathway increases radiation sensitivity in human nasopharyngeal carcinoma cells.
Shen ED; Zeng Q
Kaohsiung J Med Sci; 2019 Aug; 35(8):474-485. PubMed ID: 31271505
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.
Wang Z; Mao JW; Liu GY; Wang FG; Ju ZS; Zhou D; Wang RY
Cancer Med; 2019 Feb; 8(2):712-728. PubMed ID: 30656832
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
